OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,000 | -50.0% | 15,995 | +55.1% | 0.00% | – |
| Q4 2015 | $18,000 | -37.9% | 10,311 | -25.5% | 0.00% | – |
| Q3 2015 | $29,000 | +38.1% | 13,846 | +220.8% | 0.00% | – |
| Q2 2015 | $21,000 | -19.2% | 4,316 | +28.5% | 0.00% | – |
| Q1 2015 | $26,000 | +30.0% | 3,359 | +0.6% | 0.00% | – |
| Q4 2014 | $20,000 | +42.9% | 3,340 | -1.7% | 0.00% | – |
| Q3 2014 | $14,000 | -30.0% | 3,397 | +6.3% | 0.00% | – |
| Q2 2014 | $20,000 | -9.1% | 3,196 | -7.0% | 0.00% | – |
| Q1 2014 | $22,000 | +15.8% | 3,438 | +3.5% | 0.00% | – |
| Q4 2013 | $19,000 | -70.8% | 3,322 | -68.7% | 0.00% | -100.0% |
| Q3 2013 | $65,000 | +132.1% | 10,601 | +124.1% | 0.00% | – |
| Q2 2013 | $28,000 | – | 4,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |